Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Venous Thrombosis × edoxaban × Clear all

Phase

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 2 Neoplasms 2 Venous Thrombosis 1 Pulmonary Embolism 1 Embolism 1

Interventions

Dalteparin 3 abelacimab 2 MAA868 2 edoxaban 1 calcium heparin 1 bemiparin 1 apixaban 1 Tinzaparin 1 Rivaroxaban 1 Nadroparin 1 Heparin, Low-Molecular-Weight 1 Heparin 1 Fondaparinux 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡